MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings Long Term Debt Current 2011-2026 | ONVO
Annual Long Term Debt Current Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 521 K | 506 K | 492 K | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 521 K | 492 K | 506 K |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
3.3 M | $ 8.96 | 1.01 % | $ 597 M |  USA |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 13.67 | 0.15 % | $ 99.4 M |  Israel |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 25.94 | 0.43 % | $ 721 M | USA |
 |
DexCom
DXCM
|
21.6 M | $ 68.13 | 2.7 % | $ 26.6 B | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 154.1 | 1.4 % | $ 7.64 B | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 17.47 | 0.87 % | $ 931 M | USA |
 |
Guardant Health
GH
|
27.7 M | $ 88.35 | 1.34 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | $ 103.93 | 0.08 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.57 | 4.11 % | $ 471 M | USA |
 |
IQVIA Holdings
IQV
|
93 M | $ 168.8 | 2.43 % | $ 29 B | USA |
|
Biodesix
BDSX
|
719 K | $ 17.35 | 0.35 % | $ 2.25 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 99.75 | 2.19 % | $ 8.23 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
41 K | $ 2.86 | 0.7 % | $ 92.8 K | USA |
 |
Danaher Corporation
DHR
|
199 M | $ 195.49 | 2.14 % | $ 139 B | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
79 M | $ 122.2 | 2.45 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 199.41 | 0.23 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B |  Niderland |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.13 | 1.35 % | $ 1.44 M | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 9.02 | 7.13 % | $ 256 M | Israel |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.31 | 0.85 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.26 | 1.59 % | $ 2.01 B | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 79.31 | 1.03 % | $ 5.35 B | USA |
 |
Pacific Biosciences of California
PACB
|
448 K | $ 1.42 | 4.04 % | $ 426 M | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
838 K | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 454.33 | 0.15 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 219.09 | 1.66 % | $ 25.1 B |  Schweiz |
 |
Celcuity
CELC
|
172 K | $ 114.35 | -0.48 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
451 K | $ 17.74 | 1.95 % | $ 397 M | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
7.64 M | $ 200.3 | 1.33 % | $ 19.7 B | USA |
 |
OPKO Health
OPK
|
12.6 M | $ 1.2 | 0.42 % | $ 833 M | USA |